Senator Sees ‘Cover-Up’ by FDA on Drug Ketek
From Times Wire Reports
A Republican senator said he suspected that the Food and Drug Administration was withholding information about its review of Sanofi-Aventis’ antibiotic Ketek, which has been linked to liver damage.
“I smell a cover-up,†said Finance Committee Chairman Charles E. Grassley of Iowa after the FDA did not make one of its investigators available for a meeting. An FDA spokesman said the staffer was not available because the investigation was still underway.
More to Read
Sign up for Essential California
The most important California stories and recommendations in your inbox every morning.
You may occasionally receive promotional content from the Los Angeles Times.
